ANGLE PLC (LON:AGL)

ANGLE PLC (LON:AGL)


Share Price
53.00 p
Change
-0.5 (-0.93 %)
Market Cap
£76.05 m
Proactive Investors - Run By Investors For Investors

ANGLE PLC

ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health.

ANGLE PLC’s lead product is the Parsortix cell separation system, which can capture very rare cells from blood. This includes circulating tumor cells (CTCs) in cancer patient blood – even when there is less than one CTC in one billion healthy cells....

EPIC: AGL
Market: AIM:AGL
52-week High/Low: 76.00p / 38.00p
Sector: Pharma & Biotech
Market Cap: 76.05M
Website: www.angleplc.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of the ANGLE PLC


ANGLE PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use